Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Polysubstituted Beta Lactam. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113801050A reveals a copper-catalyzed method for highly functionalized beta-lactams, offering cost reduction in pharmaceutical intermediate manufacturing and scalable production.
Novel copper-catalyzed method for highly functionalized beta-lactams. Improves yield and enantioselectivity for antibiotic intermediates.
Patent CN113801050A details a novel copper-catalyzed interrupted Kinugasa reaction for synthesizing highly functionalized beta-lactam intermediates with excellent enantioselectivity and mild conditions.
Discover how copper-catalyzed interrupted Kinugasa reaction enables high-yield, enantioselective synthesis of polysubstituted beta-lactams for novel antibiotic development. Reduce supply chain risks.